NGGT has initiated Phase I/II clinical trials in the U.S. and China to evaluate the safety and efficacy of NGGT002 for the <a ta ...

Newborn screening is a fundamental right for every child, crucial for early diagnosis and intervention of preventable ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. | The U.S.

Group 2 encompasses diseases that need long-term or lifelong management but have relatively lower treatment costs, such as ...

Chinese researchers have made progress in localizing medullary thyroid carcinoma MTC a form of thyroid cancer that poses challenges in identifying ...

Scientists reprogrammed a woman's fat cells to become insulin-making beta cells, reversing her type 1 diabetes.

The Digital Medical and Artificial Intelligence Innovation Forum in Beijing, part of the 2024 Capital International Medical ...

Decision-makers intend for public hospitals to guarantee the basics, while foreign-owned ones provide diversified services to ...

GENEVA, SWITZARLAND / ACCESSWIRE / October 29, 2024 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...

(Image Credits: Pixabay) The Central Drugs Standard Control Organisation (CDSCO) has flagged 49 commonly used medicines for failing quality tests in the latest monthly drug alert. In its monthly ...

The benefits of puberty-blocking drugs for transgender children are drawing fresh attention after the scientist leading a major federally funded study was quoted by The New York Times as saying ...